Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Comparative Hepatology
Published in: Comparative Hepatology 1/2004

Open Access 01-01-2004 | Proceedings

Expression of growth factors in colorectal carcinoma liver metastatic patients after partial hepatectomy: implications for a functional role in cell proliferation during liver regeneration

Authors: Barbara Lukomska, Joanna Dluzniewska, Jerzy Polanski, Leszek Zajac

Published in: Comparative Hepatology | Special Issue 1/2004

Login to get access

Excerpt

Liver has a remarkable ability to replace lost cell mass. Surgical resection of hepatic lobes triggers hepatocyte replication. Normally hepatocytes have a quiescent, highly differentiated phenotype and rarely divide in adult humans [1, 2]. However, their capacity to replicate is readily activated after liver resection or after toxic injury. …
Literature
1.
2.
Kountouras J, Boura P, Lygidakis NJ: Liver regeneration after hepatectomy. Hepato-Gastroenterology. 2001, 48: 556-562.PubMed
3.
Webber EM, Godowski PJ, Fausto N: In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology. 1994, 19: 489-497. 10.1016/0270-9139(94)90029-9.CrossRefPubMed
4.
Shiota G, Okano JI, Kawasaki H, Kawamoto T, Nakamura T: Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology. 1995, 21: 106-112. 10.1016/0270-9139(95)90416-6.CrossRefPubMed
5.
Michalopoulos GK, DeFrances MC: Liver regeneration. Science. 1997, 276: 60-66. 10.1126/science.276.5309.60.CrossRefPubMed
6.
Jiang JG, Gao B, Zarnegar R: The concerted regulatory functions of the transcription factors nuclear factor-1 and upstream stimulatory factor on a composite element in the promoter of the hepatocyte growth factor gene. Oncogene. 2000, 19: 2786-2790. 10.1038/sj.onc.1203581.CrossRefPubMed
7.
Okano T, Ohwada S, Nakasone Y, Sato Y, Ogawa T, Tago K, Morishita Y: Blood transfusion causes deterioration in liver regeneration after partial hepatectomy in rats. J Surg Res. 2001, 101: 157-166. 10.1006/jsre.2001.6284.CrossRefPubMed
8.
Riordan SM, Williams R: Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure. J Hepatol. 2000, 32: 63-76. 10.1016/S0168-8278(00)80416-X.CrossRefPubMed
9.
Namekata K, Takamori S, Kojima O, Beppu T, Futagawa S: Significant changes in the serum levels of IL-6, f-HGF, and type IV collagen 7S during the perioperative period of a hepatectomy: relevance to SIRS. Surg Today. 2000, 30: 403-409. 10.1007/s005950050612.CrossRefPubMed
10.
Tomiya T, Ogata I, Fujiwara K: Transforming growth factor a levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration. Am J Pathol. 1998, 153: 955-961.PubMedCentralCrossRefPubMed
11.
Marcos A, Fisher RA, Ham JM, Shiffman ML, Sanyal AJ, Luketic VAC, Sterling RK, Fulcher AS, Posner MP: Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation. 2000, 69: 1375-1379. 10.1097/00007890-200004150-00028.CrossRefPubMed
12.
Leevy CB: Abnormalities of liver regeneration: a review. Dig Dis. 1998, 16: 88-98. 10.1159/000016852.CrossRefPubMed
13.
Mann DV, Wynnie WM, Hjelm NM, So NMC, Yeung DKW, Metreweli C, Lau WY: Human liver regeneration: hepatic energy economy is less efficient when the organ is diseased. Hepatology. 2001, 34: 557-565. 10.1053/jhep.2001.27012.CrossRefPubMed
14.
Eguchi S, Sugiyama N, Kawazoe Y: Total blood exchange suppresses the early stage of liver regeneration following partial hepatectomy in rats. Artif Organs. 1998, 22: 847-853. 10.1046/j.1525-1594.1998.06166.x.CrossRefPubMed
15.
Shiota G, Okano J: Liver diseases: clinical implications. Hepatology. 1995, 21: 106-112. 10.1016/0270-9139(95)90416-6.CrossRefPubMed
16.
Namekata K, Takamori S, Kojima M, Beppu T, Futagawa S: Significant changes in the serum levels of IL-6, h-HGF, and type IV collagen 7S during the perioperative period of a hepatectomy: relevance to SIRS. Surg Today. 2000, 30: 403-409. 10.1007/s005950050612.CrossRefPubMed
17.
Tomiya T, Ogata I, Fujiwara K: Transforming growth factor alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration. Am J Pathol. 1998, 153: 955-961.PubMedCentralCrossRefPubMed
18.
Kimura F, Miyazaki M, Suwa T: Correlation between human hepatocyte growth factor and interleukin-6 concentrations after surgery. Hepatogastroenterology. 1999, 46: 1030-1035.PubMed
19.
von Schweinitz D, Faundez A, Teichmann B: Hepatocyte growth-factor-scatter factor can stimulate post-operative tumor-cell proliferation in childhood hepatoblastoma. Int J Cancer. 2000, 85: 151-159. 10.1002/(SICI)1097-0215(20000115)85:2<151::AID-IJC1>3.0.CO;2-6.CrossRefPubMed
20.
Yoshinaga Y, Matsuno Y, Fujita S: Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflammatory lesions of various organs. Jpn J Cancer Res. 1993, 84: 1150-1158.CrossRefPubMed
21.
Nakamura T, Matsumoto K, Kiritoshi A, Tano Y, Nakamura T: Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: In Vitro analysis of tumor-stromal interactions. Cancer Res. 1997, 57: 3305-3313.PubMed
22.
Ho RT, Liew C, Lai KN: The expression of hepatocyte growth factor (HGF) and interleukin 6 (IL-6) in damaged human liver and kidney tissues. Hepatogastroenterology. 1999, 46: 1904-1909.PubMed
23.
Zarnegar R, Michalopoulos GK: The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol. 1995, 129: 1177-1180. 10.1083/jcb.129.5.1177.CrossRefPubMed
24.
Tanigawa K, Sakaida I, Masuhara M, Hagita M, Okita K: Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer (NK) cell activity in human liver diseases. J Gastroenterol. 2000, 35: 112-119. 10.1007/s005350050023.CrossRefPubMed
25.
Ramadori G, Armbrust T: Cytokines in the liver. Eur J Gastroenterol Hepatol. 2001, 13: 777-784. 10.1097/00042737-200107000-00004.CrossRefPubMed
26.
Aldana PR, Goerke ME, Carr SC, Tracy TF: The expression of regenerative growth factors in chronic liver injury and repair. J Surg Res. 1994, 57: 711-717. 10.1006/jsre.1994.1206.CrossRefPubMed
27.
Kiss A, Szepesi A, Lotz G, Nagy P, Schaff Z: Expression of Transforming growth factor-alpha in hepatoblastoma. Cancer. 1998, 83: 690-697. 10.1002/(SICI)1097-0142(19980815)83:4<690::AID-CNCR9>3.0.CO;2-O.CrossRefPubMed
28.
Jo M, Stoltz DB, Esplen KE, Dorko K, Michalopoulos GK, Strom SC: Cross-talk between epidermal growth factor receptor and c-MET signal pathways. J Biol Chem. 2000, 275: 8806-8811. 10.1074/jbc.275.12.8806.CrossRefPubMed
29.
Pediaditakis P, Lopez-Talavera JC, Petersen B, Monga SPS, Michalopoulos GK: The processing and utilization of Hepatocyte growth factor/Scatter factor following partial hepatectomy in the rat. Hepatology. 2001, 34: 688-693. 10.1053/jhep.2001.27811.PubMedCentralCrossRefPubMed
30.
De Jong KP, Stellema R, Karrenbeld A, Koudstaal J, Gouw ASH, Sluiter WJ, Peeters PMJG, Slooff MJH, De Vries EGE: Clinical relevance of transforming growth factor a, epidermal growth factor receptor, p53, and ki67 in colorectal liver metastases and corresponding primary tumors. Hepatology. 1998, 28: 971-979. 10.1016/S0168-8278(98)80345-0.CrossRefPubMed
Metadata
Title
Expression of growth factors in colorectal carcinoma liver metastatic patients after partial hepatectomy: implications for a functional role in cell proliferation during liver regeneration
Authors
Barbara Lukomska
Joanna Dluzniewska
Jerzy Polanski
Leszek Zajac
Publication date
01-01-2004
Publisher
BioMed Central
Published in
Comparative Hepatology / Issue Special Issue 1/2004
Electronic ISSN: 1476-5926
DOI
https://doi.org/10.1186/1476-5926-2-S1-S52

Other articles of this Special Issue 1/2004

Comparative Hepatology 1/2004 Go to the issue

Proceedings

3-D structure of extracellular matrix regulates gene expression in cultured hepatic stellate cells to induce process elongation

Proceedings

Histopathological characterization of hepatocellular carcinomas which are undetected by dynamic computed tomography

Proceedings

Role of Hepatic Stellate Cells in the Early Phase of Liver Regeneration in Rat: Formation of Tight Adhesion to Parenchymal Cells

Proceedings

Intercellular Adhesive Structures Between Stellate Cells – An Analysis in Cultured Human Hepatic Stellate Cells

Proceedings

Peroxynitrite formation and sinusoidal endothelial cell injury during acetaminophen-induced hepatotoxicity in mice

Proceedings

The effect of cytochalasin B – Loaded liposomes on the ultrastructure of the liver sieve
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits